Locations:
Min Investment:
Max Investment:
Target Investment:
Executive Program
Doctor of Philosophy - PhD (Honoris Causa)
Master of Business Administration - MBA
Master of Science - MSc
Master of Science - MS
Bachelor of Science - BS
2013
2013
Govin Holdings is Singapore-headquartered company with a focus on Pharma Advisory, Pharma Supply-chain of Complex Drugs, Controlled Drugs, Psychotropic Drugs, and Strategic investments. Our core market is Asia and we try to add value by partnering with various Pharmaceuticals and Healthcare companies across the globe to serve local hospitals and government agencies.
2014
2014
Govin Capital is a Singapore-based Investment Company that invests in early-stage innovative companies in Digital Healthcare, Medtech, Diagnostics, Artificial Intelligence & EdTech Startups. The companies have a scalable business model and backed by a strong management team. We focus on Singapore, US and Indian markets. To-date, Govin Capital has made several investments and incubated several Startups. Govin Capital is funded by Institutional investors and Family Offices from Europe, USA, India and Singapore.
2022
2024
2022 - 2024
Singapore-headquartered digital health company with a EU CE mark & Singapore HSA approved AI-powered wearable device, KIMIA Recover, for digital knee pain monitoring in patients, post Total Knee Replacement (TKR) surgeries. Recipient of grants from Temasek Foundation, SingHealth and James Dyson Awardee.
2022
National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad is an "Institute of National Importance" with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences. NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India. Later, the DOP established 6 new NIPERs across the country including NIPER-Hyderabad which started functioning from 19th October 2007, from the premises of erstwhile R&D Centre of IDPL, Balanagar, Hyderabad. Vision To stimulate and facilitate R&D activities in Pharmaceutical Sciences aiming towards New Product/Solution/Technology development. Objectives To address some of the challenges being faced by pharmaceutical entrepreneurs, start-ups and MSMEs To synergize the strengths and capabilities of BioNest incubatees and NIPER-Hyderabad in developing efficient and cost-effective processes and technologies for Active Pharmaceutical Ingredients (API), Key Intermediates & Finished Pharmaceutical Products Development and Assessment of the characterization tools for bioequiva lent generic pharmaceutical product development with improved "Quality", "Safety" & "Efficacy" (SQEM) To provide cost effective facilities for the incubatees to fulfill the regulatory requirements for commercial uses of the bioactive(s), which would be expediting the process to market the affordable medicine
2021
2021
Alternative proteins, whether they are produced from plants, grown from animal cells, or created using microbial organisms, can give us the same food we enjoy today but without the unsustainable cost to the environment and the suffering of other inhabitants on this planet. We have a responsibility to create a better future for the generations that follow, to treat every living being on this planet with dignity, and to care for the only home we have as a species (even when we get to Mars, we dare say Earth will remain the planet of choice). So, to the entrepreneurs who are building the next generation of food by creating these alternative protein sources, we believe you hold the key to a better future. We’re here to help you build the next wave of great technologies and companies. We exist to help you accelerate and scale your efforts, to achieve your dreams. In the process, you will create a better future for all of us. We honor your work, and feel privileged to be a small part of it.
2021
2021
Aktivolabs is a Singapore-headquartered digital health company where its mottos is that healthy people make happy, productive and connected societies and by harnessing the value of science, one can lessen chronic disease and empower people to live long and healthy lives.
2016
2021
2016 - 2021
http://cialfo.co
2020
Leading K-12 EdTech company in Singapore focused on adding value thru its unique AI-powered Kidsquest platform and 360 degree immersive experience.
2019
Kare4U Healthcare solutions aims to disrupt the healthcare insurance industry with its novel blockchain-powered platform for real-time processing of its healthcare insurance claims. Kare4U management team and founders have spent more than a decade in Infosys, Bangalore. Recently the company has signed a major partnership MOU with Future Generali for India market and are in discussions with other major insurance players for the global markets.
2016
2016